U.S. markets open in 7 minutes
  • S&P Futures

    3,845.00
    +6.00 (+0.16%)
     
  • Dow Futures

    31,615.00
    +150.00 (+0.48%)
     
  • Nasdaq Futures

    12,620.25
    -43.50 (-0.34%)
     
  • Russell 2000 Futures

    2,208.80
    +19.10 (+0.87%)
     
  • Crude Oil

    65.74
    -0.35 (-0.53%)
     
  • Gold

    1,693.20
    -5.30 (-0.31%)
     
  • Silver

    25.33
    +0.05 (+0.19%)
     
  • EUR/USD

    1.1876
    -0.0048 (-0.40%)
     
  • 10-Yr Bond

    1.5820
    +0.0280 (+1.80%)
     
  • Vix

    25.97
    -2.60 (-9.10%)
     
  • GBP/USD

    1.3842
    +0.0014 (+0.10%)
     
  • USD/JPY

    108.6960
    +0.3140 (+0.29%)
     
  • BTC-USD

    50,838.15
    +183.82 (+0.36%)
     
  • CMC Crypto 200

    1,027.54
    +84.37 (+8.95%)
     
  • FTSE 100

    6,645.74
    +15.22 (+0.23%)
     
  • Nikkei 225

    28,743.25
    -121.07 (-0.42%)
     

Abond CRO Announces That Mr. Zoran Antonijevic Is Their New Vice President, Statistical Consulting

·2 min read

Dr. Phil Doren, Chief Executive Officer and Vice President, is pleased to announce today that Zoran Antonijevic is the Vice President, Statistical Consulting at Abond CRO Inc. "With this single appointment, we have greatly strengthened our capability to address customers’ needs in statistical consulting for drug development," Doren said.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210223005655/en/

(Photo: Business Wire)

Mr. Antonijevic is an industry thought leader with cutting edge knowledge of innovative methods and strategies including adaptive design, platform trials, and program/portfolio optimization. He has extensive experience with drug development, department development and decision making. He is the long-time Chair and leader of the DIA Adaptive Design Scientific Working Group. His background covers numerous therapeutic areas and his professional strengths include development strategy, thought leadership and vision, consulting, program and portfolio level optimization, master protocols, decision science, analytics, due diligence, regulatory, department vision, processes and metrics and talent identification.

Prior to coming to Abond CRO, Mr. Antonijevic’s CRO experience included leading Biometrics, where he managed all biostatistics, programming, data management and medical writing activities, and previously he was Senior Director of Strategy, and the Senior Director/Director, Center for Statistics in Drug Development Innovation.

His experience at major pharmaceutical companies includes Innovative & Adaptive Design Executive Director and Head of Development Design Center, and, very early in his career, was a Principal Statistician.

Mr. Antonijevic formed his own consulting company and while doing that work, served as Chief Scientific Officer for a global health firm specializing in highly-efficient clinical study designs and biostatistical methods. He began his career at the Harvard School of Public Health, AIDS Clinical Trials Group (ACTG).

"Abond CRO is excited to have Zoran join our company. His leadership, experience and amazing technical expertise greatly enhances our foundational and long-standing tradition of excellent direction and support in statistical consulting for our customers," Doren added.

About Abond CRO Inc. (www.abondcro.com)

Abond is a full-service clinical research organization dedicated to providing specialized clinical research support for the pharmaceutical and medical device industries since its founding in 1974 (incorporation in 1985). They deliver everything you’d expect from a full-service CRO — consulting, clinical operations, data management, statistical analysis — and a few things that set them apart: honesty, focus, and responsibility. Abond works with small startup organizations to established pharmaceutical and medical device leaders around the world.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210223005655/en/

Contacts

Abond CRO Inc.
Charley Bratton
919-316-8111
cbratton@abondcro.com